Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

COAGCOAG
1 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in HEMAB THERAPEUTICS HOLDI

Yes. Price T Rowe Associates holds 746,040 shares of COAG (Hemab Therapeutics Holdi), worth $27.4M, as of its Q2 2026 13F filing.

Current Value

$27.4M

Current Shares

746,040

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
746,040
-
$27.4M0.0%$36.73
40

Other major holders of COAG: RA CAPITAL MANAGEMENT, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used